B lymphoblastoid cell lines immortalized with P3HR1/633 Epstein-Barr virus (EBV), which has a deletion in the EBV nuclear antigen leader protein (EBNA-LP) gene, were transfected with a vector expressing wild-type EBNA-LP. The EBNA-LP transfectants grew out faster under G418 selection than control cells but expression of EBNA-LP made no significant difference to growth rate or saturation density of the resulting established cell lines. When the cells expressing EBNA-LP were allowed to grow to saturation and then diluted in fresh medium they underwent DNA synthesis more rapidly than control cultures.
Of the 80 or so genes encoded by Epstein-Barr virus (EBV), only 11 have been shown to be expressed during virus latency in B cells immortalized by EBV (reviewed in Fields & Knipe, 1990) . Therefore these genes are possibly involved in initiation and maintenance of the immortalized state of the infected cell. One of these genes encodes the EBV nuclear antigen leader protein (EBNA-LP) (Sample et al., 1986; Speck et al., 1986 ) also known as EBNA 4 and EBNA 5 (Dillner et al., 1986) . The highly spliced open reading frame (ORF) for EBNA-LP spans the major internal repeat region of the virus and produces a protein composed of several 66 amino acid repeats, followed by 45 amino acids of unique carboxy-terminal sequence (Bodescot et al., 1984) . EBNA-LP is phosphorylated (Petti et al., 1990; Sauter et al., 1988) and subcellular fractionation of EBV-infected cells has localized EBNA-LP to the nucleus (Dillner et al., 1986; Rowe et al., 1987) . Indirect immunofluorescence with the monoclonal antibody JF186 specific for EBNA-LP (Finke et al., 1987) and affinity-purified antibodies specific for EBNA-LP gives a characteristic picture of coarse nuclear granules, perhaps suggesting a concentration of EBNA-LP in a few subnuclear particles (Finke et al., 1987; Jiang et al., 1991; Petti et al., 1990 ).
The precise function of EBNA-LP is unknown. The non-transforming EBV strains P3HR1 and Daudi contain deletions which remove the entire EBNA 2 gene and the 3' unique sequences of EBNA-LP (Delius & Bornkamm, 1978; Jones et al., 1984; Menezes et al., 1975; Miller et al., 1974; Raab-Traub et al., 1978; Rabson et al., 1982) . Complete repair of the P3HR1 deletion by recombination results in apparently wildtype immortalizing EBV (Cohen et al., 1989; Hammerschmidt & Sugden, 1989) . Recombination events that restore EBNA 2 to P3HR1 virus, without restoring full-length EBNA-LP, also restore immortalization (Cohen et al., 1989; Hammerschmidt & Sugden, 1989; Mannick et al., 1991) but the efficiency of immortalization by the viral strain expressing a truncated EBNA-LP (633 virus) was approximately 10-fold lower than that of the P3HR1 recombinant which has all the EBNAs intact (Hammerschmidt & Sugden, 1989; Mannick et al., 1991) . EBV 633 has a 500 bp deletion in the BamHI Y fragment which removes the last two coding exons (Y1 and Y2) from the EBNA-LP ORF.
EBV was induced from 633 cells and used to infect fresh B lymphocytes from an EBV-negative donor (BP). The immortalized BP lymphocytes were initially cultured over human fibroblast feeder cells (MRC-5), which in our hands were essential for successful immortalization by EBV 633. Similar feeder cell dependence has recently been reported by Mannick et al. (1991) . Initially both the 633 and BP cell lines were dependent on feeder cells for growth but after about 6 weeks of culture the feeder cells became unnecessary. The feeder-independent cells were used in the subsequent experiments described in this paper.
An EBNA-LP expression vector (pSNOC-LP) carrying a G418 resistance locus was constructed using the cytomegalovirus immediate early promoter and the simian virus 40 poly(A) sequences to express EBNA-LP. Both this construct and the vector, pSNOC, were electroporated (Buschle et al., 1990) separately into either the original 633 virus-infected cells provided by Dr B. Sugden or into BP cells. The transfected ceils were seeded into wells and selected for their resistance to G418 (150 to 200 Ixg/ml). pSNOC contains the oriP element of EBV; the transfected DNA was presumably maintained as a multicopy episome. The lines derived from 633 cells were called 633-SNOC-LP and 633-SNOC (transfected with pSNOC-LP or pSNOC respectively) and the corresponding lines in BP cells were called BP-SNOC-LP and BP-SNOC. Cells in multiple wells of both the 633-SNOC-LP and BP-SNOC-LP lines came through the drug selection faster than the corresponding SNOC transfectants, and could be transferred to flasks earlier, indicating that expression of EBNA-LP was helping the outgrowth of the transfected cells. Resulting lines were checked for EBNA-LP expression by Western blot analysis (Fig. 1) . The 633-SNOC and BP-SNOC lines expressed only the truncated EBNA-LP from the 633 virus, whereas 633-SNOC-LP and BP-SNOC-LP expressed both the truncated EBNA-LP and the full-length version from the pSNOC-LP plasmid. The size of the truncated EBNA-LP protein expressed from the 633 virus had decreased in the BP cells, consistent with our previous studies showing that the number of repeats in IR-1 is susceptible to change during the course of virus induction and reinfection (Allan & Rowe, 1989) . There has been a reduction of about 7K in the truncated protein in the BP transfectants, which implies a loss of one repeat in the viral genome. The higher Mr bands detected on these Western blots are EBNA-1 and EBNA-2 and the presence of LP has no apparent effect on the levels of these proteins.
Immunofluorescence analysis of EBNA-LP (Fig. 2 ) expressed in either BP-SNOC or BP-SNOC-LP cells showed the characteristic granular nuclear fluorescence pattern reported previously (Petti et al., 1990; , confirming that the C-terminal sequences deleted in EBNA-LP of EBV 633 are not required for the correct cell localization of EBNA-LP.
The cell lines that expressed either the truncated EBNA-LP alone or the truncated and full-length protein were used to test the effect of the intact gene on the growth properties of EBV-immortalized B cells. The growth curves of the transfected lines were established by plating them out at the same cell density and then counting the cells at appropriate days thereafter. With both pairs of cell lines, the SNOC transfectants have essentially the same growth curve as the SNOC-LP lines (Fig. 3) . The presence of a full-length EBNA-LP does not therefore appear to have a significant effect on the growth rate of these established cell lines. Usually the SNOC-LP cells reached saturation at a slightly higher density but any such effect was very small. Many different dilution and feeding experiments were performed to identify a different in growth properties between the SNOC and SNOC-LP transfectants. It was only when density-saturated cells were serum-stimulated by diluting them in fresh medium that a significant effect was observed. In these experiments the two lines in each cell line pair were plated out at the same cell density, 5 × 104 cells/ml, and left for approximately 1 week until they were both saturated. At this stage, the cells were counted again and found to be at very similar cell densities (approximately 1 x 106 cells/ml). They were t h e n diluted twofold with fresh growth m e d i u m a n d aliquots were pulse-labelled with [3H]thymidine for 2 h periods at 2 h intervals thereafter (Fig. 4) . It was found consistently that, after such addition of fresh m e d i u m , those lines which c o n t a i n e d full-length E B N A -L P had a three-to fourfold greater increase in [3H]thymidine incorporation than the lines that expressed only the truncated E B N A -L P . This phenotype was observed in both cell line pairs a n d the results suggest that the increased D N A synthesis in saturated 633-SNOC-LP and B P -S N O C -L P cells upon addition of fresh m e d i u m is a result of fulllength E B N A -L P being present in the cells. The changing ratios of 3H incorporation during the time courses indicate that the difference between the S N O C a n d S N O C -L P transfectants is not simply a consequence of different isotope dilution of Short communication dilution the cultures both contained a similar high proportion of cells excluding trypan blue (cell counts were of those excluding trypan blue) so the saturated SNOC cultures continued live cells and both lines could be passaged from such saturated cultures.
In those experiments, the twofold dilution was carried out by adding 2 ml of fresh medium to 2 ml of saturated ceils. In other experiments, the saturated cells were collected by centrifugation and the 2 ml of conditioned medium was removed before the addition of 4 ml of fresh medium. In this case, it was found that the uptake of [3H]thymidine was the same in the SNOC-LP and SNOC transfectants (data not shown). This type of experiment was also performed at both 1 and 10% foetal calf serum and extending the period within which the short pulse labelling was done up to 5 days. Still no difference was observed between the cell lines when the saturated medium had been removed. These results may indicate that the conditioned medium was important for the effect of EBNA-LP on DNA synthesis. Cocultivation experiments using semipermeable membranes also support the notion that LP reduces growth factor dependence during outgrowth of lymphocyte cell lines (Mannick et al., 1991) . Our experiments have been complicated by a tendency for the transfected cells to change their growth properties upon prolonged culture (i.e. more than 3 or 4 months). For the experiments presented in this paper, aliquots of early passage transfectants were grown for 1 to 2 months and reproducibly gave the results indicated. However on four separate occasions after about 3 to 4 months in culture the growth of the control pSNOC transfectants slowed and the cultures eventually died. The EBNA-LP transfectants continued to grow. These observations have led us to wonder whether cell lines infected with EBV lacking EBNA-LP are truly immortal. Further experiments will be required to establish this point and to investigate a possible growth factor involvement in EBNA-LP function.
Although it was concluded earlier (Hammerschmidt & Sugden, 1989 ) that EBNA-LP is not absolutely required for B cell immortalization by EBV, it was evident from those data that immortalization was much less efficient with EBV 633 than with the wild-type virus. Those immortalizations were performed over feeder cells and when we passaged the 633 virus to make the BP cell line, feeder cells proved to be essential to obtain successful outgrowth of immortalized cells (wild-type virus did not require feeder cells in the same conditions). EBNA-LP also helped the outgrowth of the transfected cell lines, so there are clear indications that EBNA-LP contributes to the efficiency of the immortalization process. Our results are consistent with the recent report of Mannick et al. (1991) in this regard. Our experiments have also investigated the contribution of EBNA-LP to the growth of established immortalized lines. There was no substantial difference in growth rate or saturation density but upon refeeding saturated cultures, cells expressing EBNA-LP underwent a rapid burst of DNA synthesis which was essentially absent in the control cultures. The explanation for this remains unclear but it might imply that EBNA-LP prevents the cells from arresting so severely upon saturation, permitting the cells to enter the S phase more rapidly and synchronously.
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